SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 239,240.89 |
Enterprise Value ($M) | 263,168.89 |
Book Value ($M) | 44,560.00 |
Book Value / Share | 17.64 |
Price / Book | 5.37 |
NCAV ($M) | -31,952.00 |
NCAV / Share | -12.65 |
Price / NCAV | -7.49 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.21 |
Return on Assets (ROA) | 0.16 |
Return on Equity (ROE) | 0.41 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.15 |
Current Ratio | 1.36 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 38,782.00 |
Assets | 117,106.00 |
Liabilities | 70,734.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 64,168.00 |
Operating Income | 24,031.00 |
Net Income | 17,117.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 21,468.00 |
Cash from Investing | -7,734.00 |
Cash from Financing | -7,032.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 10.02 | 3.47 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,175,311 | 8,790,939 | 13.37 | |
1,598,069 | 13,335,268 | 11.98 | |
1,371,612 | 9,207,772 | 14.90 | |
1,407,857 | 11,256,126 | 12.51 | |
1,324,704 | 12,535,594 | 10.57 | |
(click for more detail) |
Similar Companies | |
---|---|
HYAC – Haymaker Acquisition Corp. 4 | JNJ – Johnson & Johnson |
LLY – Eli Lilly and Company | NUVB – Nuvation Bio Inc. |
OGN – Organon & Co. |